Header Logo

Connection

Poorva Bindal to CTLA-4 Antigen

Back to Details
This is a "connection" page, showing publications Poorva Bindal has written about CTLA-4 Antigen.
Poorva Bindal
Connection Strength
0.043
CTLA-4 Antigen
  1. Kethireddy N, Thomas S, Bindal P, Shukla P, Hegde U. Multiple autoimmune side effects of immune checkpoint inhibitors in a patient with metastatic melanoma receiving pembrolizumab. J Oncol Pharm Pract. 2021 Jan; 27(1):207-211.
    View in: PubMed
    Score: 0.043
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.